Gregory J. Gores
Mayo Clinic
Young-Suk Lim
Asan Medical Center, University of Ulsan College of Medicine
Peyton Classon
Mayo Clinic
Avleen Kaur
Montefiore Medical Center
Katherine Ni
Montefiore Medical Center
Won Kim
Seoul National University
Alyson Kaplan
New York-Presbyterian Hospital-Columbia
Osman Berk Usta
Massachusetts General Hospital
Treatment Option for Unresectable Hepatocellular Carcinoma
Supported by: AstraZeneca
This promotional program covers the HIMALAYA trial of the IMFINZI + IMJUDO immunotherapy regimen in patients with unresectable HCC. The presentation has been updated with results from the HIMALAYA 4-year exploratory analysis sho